AMENDMENT NO.4 TO LICENSING AND ASSIGNMENT AGREEMENTLicensing and Assignment Agreement • August 11th, 2020 • Satsuma Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 11th, 2020 Company IndustryThis Amendment No.4 (“Amendment No.4”) to the Licensing and Assignment Agreement by and between Satsuma Pharmaceuticals, Inc. (“Company”) and Shin Nippon Biomedical Laboratories, Ltd. (“SNBL”) of June 30, 2016 (the “Agreement”) is dated as of May 25, 2020 (“Amendment No.4 Effective Date”).